Lemborexant Treatment of Insomnia Linked to Epilepsy

Part of paid clinical trials in Durham, North Carolina.

Sponsor
University of Manitoba
Study ID
NCT06262594
Phase
PHASE3
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Lemborexant — DRUG
    Drug is administered
  • Placebo — DRUG
    Drug is administered

Study Details

The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy.

Key Dates

Start date
Oct 29, 2024
Status verified
Feb 2025
Primary completion
Apr 18, 2026
Completion
Apr 18, 2027

Study Design

Enrollment
26 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Placebo Comparator: Placebo First
    0mg
  • Active Comparator: Investigational Product First
    10mg qhs

Primary Outcome Measure

WASO [ Time Frame: 36 Days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Duke UniversityDurhamNorth Carolina27708
Birgit Frauscher, MD, PhD
[email protected]
919-681-1700

Find similar trials in Durham, NC

By condition
Epilepsy
By specialty
NeurologyBrain disorders
By research site
Duke University· Durham, NC

Related Studies